Financiere des Professionnels’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Hold
201,100
0.27% 79
2026
Q1
$5.65M Sell
201,100
-257,113
-56% -$6.85M 0.33% 63
2025
Q4
$11.4M Buy
458,213
+53,084
+13% +$1.34M 0.65% 37
2025
Q3
$10.3M Sell
405,129
-22,061
-5% -$545K 0.59% 42
2025
Q2
$10.4M Buy
427,190
+53,693
+14% +$1.25M 0.63% 40
2025
Q1
$9.46M Sell
373,497
-15,509
-4% -$406K 0.61% 46
2024
Q4
$10.3M Buy
389,006
+125,233
+47% +$3.4M 0.72% 41
2024
Q3
$7.63M Buy
263,773
+3,163
+1% +$92.3K 0.52% 64
2024
Q2
$7.25M Buy
260,610
+38,158
+17% +$1.05M 0.57% 53
2024
Q1
$6.17M Hold
222,452
0.5% 67
2023
Q4
$6.4M Buy
222,452
+85,597
+63% +$2.59M 0.56% 57
2023
Q3
$4.54M Buy
+136,855
New +$4.84M 0.43% 70

Other funds holding PFE

Financiere des Professionnels's PFE Position: Q2 2026 in Review

Financiere des Professionnels held its Pfizer (PFE) position steady in Q2 2026 at 201,100 shares worth $4.84M. The position accounts for 0.27% of the portfolio, ranked #79.

Financiere des Professionnels first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $11.4M in Q4 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Financiere des Professionnels held 201,100 shares of Pfizer worth $4.84M as of Q2 2026.
  • Financiere des Professionnels left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.27% of Financiere des Professionnels's portfolio in Q2 2026, its #79 holding.
  • Financiere des Professionnels first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • Financiere des Professionnels's Pfizer position peaked at $11.4M in Q4 2025.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.